Products / Neuroscience

Renacenz

Cerebrolysin 215,2 mg

Cerebrolysin is indicated for the treatment of organic, metabolic and neurodegenerative disorders of the brain, especially Alzheimer-type senile dementia, post apoplectic disorders, traumatic brain injury and post surgical trauma, contusion or brain concussion.

Therapeutic Action

Neurotrophic - Neuroprotector

Presentations

5 ampoules x 10 ml

Renacenz Cerebrolysin 215,2 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use